Paper29018174
Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation.
Kristensen SL and 14 others. Circ Heart Fail, 2017. Cited by 61 papers, by iCite.
Cite this record
ConductScience Library. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation. Papers, record 29018174. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29018174
- Disease
- heart failure311 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation.
- PubMed
Connected records2
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics25
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Atrial Fibrillation | Major topic |
| Cardiovascular Diseases | Major topic |
| Heart Failure | Major topic |
| Hospitalization | Major topic |
| Natriuretic Peptide, Brain | Major topic |
| Peptide Fragments | Major topic |
| Aged | |
| Amides | |
| Aminobutyrates | |
| Angiotensin Receptor Antagonists | |
| Antihypertensive Agents | |
| Biphenyl Compounds | |
| Case-Control Studies | |
| Cohort Studies | |
| Drug Combinations | |
| Enalapril | |
| Female | |
| Fumarates | |
| Humans | |
| Male | |
| Middle Aged | |
| Prognosis | |
| Stroke Volume | |
| Tetrazoles | |
| Valsartan |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT00853658 | Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure | Derived from the trial | Yes | ClinicalTrials.gov |
| NCT01035255 | This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure | Derived from the trial | Yes | ClinicalTrials.gov |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 29018175 | Lessons Learned and to Be Learned About the Use of N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure and Atrial Fibrillation. | https://conductscience.org/library/papers/29018175 |
Source PubMed
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 61 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42650951 | Myocardial Function Assessment After Cardioversion in Persistent Atrial Fibrillation: Current Evidence and Future Directions. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42650951 | PubMed |
| 41711708 | Atrial fibrillation increases left and right atrial pressures in patients with chronic heart diseases. | ESC Heart Fail | 2026 | https://conductscience.org/library/papers/41711708 | PubMed |
| 41209853 | N‑Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) as a Biomarker in Heart Failure With Preserved Ejection Fraction (HFpEF) Versus Heart Failure With Reduced Ejection Fraction (HFrEF): The Way Forward in the Age of Proteomics. | Cureus | 2025 | https://conductscience.org/library/papers/41209853 | PubMed |
| 40865190 | Prognostic Implications of Preoperative N-Terminal Pro-B-Type Natriuretic Peptide Dynamics in Patients Undergoing Cardiac Surgery. | JACC Adv | 2025 | https://conductscience.org/library/papers/40865190 | PubMed |
| 40726817 | Left Atrial Remodeling Parameters and Brain Natriuretic Peptide Levels in Nonvalvular Atrial Fibrillation. | J Saudi Heart Assoc | 2025 | https://conductscience.org/library/papers/40726817 | PubMed |
| 40519716 | Comparison of Natriuretic Peptide Levels in Sinus Rhythm and Atrial Fibrillation in Acute Heart Failure. | Int J Heart Fail | 2025 | https://conductscience.org/library/papers/40519716 | PubMed |
| 40091615 | The addition of alpha-ketoglutarate to NT-proBNP improves the prediction of long-term all-cause mortality in acute heart failure patients. | Ann Med | 2025 | https://conductscience.org/library/papers/40091615 | PubMed |
| 40066216 | Prognostic Value of B-Type Natriuretic Peptide Level in Patients With Heart Failure With a Higher Left Ventricular Ejection Fraction. | Circ Rep | 2025 | https://conductscience.org/library/papers/40066216 | PubMed |
| 39139790 | A bibliometric analysis of light chain amyloidosis from 2005 to 2024: research trends and hot spots. | Front Med (Lausanne) | 2024 | https://conductscience.org/library/papers/39139790 | PubMed |
| 39129426 | Prognostic factors in Chinese patients with immunoglobulin light chain amyloidosis: a scoping review and meta-analysis. | Ann Med | 2024 | https://conductscience.org/library/papers/39129426 | PubMed |
| 39076854 | Trace Elements Open a New Direction for the Diagnosis of Atherosclerosis. | Rev Cardiovasc Med | 2023 | https://conductscience.org/library/papers/39076854 | PubMed |
| 38939808 | FGF-23, Left Ventricular Hypertrophy, and Mortality in Patients With CKD: A Revisit With Mediation Analysis. | JACC Adv | 2024 | https://conductscience.org/library/papers/38939808 | PubMed |
| 38115625 | N-terminal pro-B-type natriuretic peptide concentrations, testing and associations with worsening heart failure events. | ESC Heart Fail | 2024 | https://conductscience.org/library/papers/38115625 | PubMed |
| 37168845 | Prevalence and Correlates of Elevated NT-proBNP in Pregnant Women in the General U.S. Population. | JACC Adv | 2023 | https://conductscience.org/library/papers/37168845 | PubMed |
| 37084113 | Echocardiographic phenotype for refined risk stratification and treatment selection in light chain amyloidosis with heart failure. | J Cancer Res Clin Oncol | 2023 | https://conductscience.org/library/papers/37084113 | PubMed |
| 36926939 | Bone Morphogenetic Protein 10-A Novel Biomarker to Predict Adverse Outcomes in Patients With Atrial Fibrillation. | J Am Heart Assoc | 2023 | https://conductscience.org/library/papers/36926939 | PubMed |
| 36614172 | The Association of Glucose Control with Circulating Levels of Red Blood Cell-Derived Vesicles in Type 2 Diabetes Mellitus Patients with Atrial Fibrillation. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36614172 | PubMed |
| 36543554 | Natriuretic peptide testing and heart failure diagnosis in primary care: diagnostic accuracy study. | Br J Gen Pract | 2023 | https://conductscience.org/library/papers/36543554 | PubMed |
| 35112889 | Interactions Between Atrial Fibrillation and Natriuretic Peptide in Predicting Heart Failure Hospitalization or Cardiovascular Death. | J Am Heart Assoc | 2022 | https://conductscience.org/library/papers/35112889 | PubMed |
| 35079000 | Coding and regulatory variants are associated with serum protein levels and disease. | Nat Commun | 2022 | https://conductscience.org/library/papers/35079000 | PubMed |
Drugs4
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| VALSARTAN | CHEMBL1069 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL1069 | ChEMBL |
| ALISKIREN | CHEMBL1639 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL1639 | ChEMBL |
| SACUBITRIL | CHEMBL3137301 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL3137301 | ChEMBL |
| ENALAPRIL | CHEMBL578 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL578 | ChEMBL |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- References
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29018174
GET https://conductscience.org/api/papers/v1/29018174/cited_by?page=2